This collaborative project between Belgium, the Netherlands, Luxembourg and Austria focuses on joint health technology assessment and joint procurement of medicines, allowing Member States to pool data and negotiate prices with pharmaceutical companies. In particular, the initiative focuses on making innovative treatments affordable and accessible across borders and addresses important information and economic gaps in healthcare.